ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 78 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $704,050 | -36.1% | 146,677 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $1,101,544 | +69.8% | 146,677 | +2.2% | 0.00% | +33.3% |
| Q1 2023 | $648,652 | -61.6% | 143,507 | -4.3% | 0.00% | -62.5% |
| Q4 2022 | $1,689,734 | +16.9% | 149,932 | -0.8% | 0.01% | +14.3% |
| Q3 2022 | $1,446,000 | +80.5% | 151,112 | +52.7% | 0.01% | +75.0% |
| Q2 2022 | $801,000 | +172.4% | 98,964 | +2387.2% | 0.00% | +300.0% |
| Q3 2021 | $294,000 | – | 3,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $716,436,000 | 71.38% |
| Logos Global Management LP | 3,156,981 | $233,175,000 | 16.81% |
| Vivo Capital, LLC | 4,220,048 | $311,693,000 | 14.00% |
| Cormorant Asset Management, LP | 1,012,079 | $74,752,000 | 3.04% |
| Redmile Group, LLC | 864,435 | $63,847,000 | 1.11% |
| Nan Fung Group Holdings Ltd | 41,950 | $3,098,000 | 0.99% |
| Artal Group S.A. | 500,000 | $36,930,000 | 0.83% |
| SPHERA FUNDS MANAGEMENT LTD. | 128,706 | $9,506,000 | 0.80% |
| Pier Capital, LLC | 75,362 | $5,566,000 | 0.58% |
| Financial Advisory Group | 31,417 | $2,320,000 | 0.51% |